GlassScriptPhysician profile
Brian Daniel Mccauley
NPI 1538517313
$19,767.90
in general payments reported to CMS, 2019-2025
19 companies · $8,517 in 2025
The $8,517 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $134 · 2021: $444 · 2022: $3,212 · 2023: $6,505 · 2024: $810 · 2025: $8,517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,191 · Food and Beverage: $6,449 · Education: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,190.74 |
| Food and Beverage | $6,449.17 |
| Education | $192.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,662.34 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| W. L. Gore & Associates, INC. | $1,499.15 | 2022-2023 | Gore Cardioform Septal Occluder, Gore Bio-A Tissue Reinforcement |
| Edwards Lifesciences Corporation | $1,315.83 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Biotronik INC. | $1,034.38 | 2021-2023 | Orsiro Mission, Pantera Leo, Recross |
| Abiomed | $973.88 | 2020-2025 | Impella |
| Abbott Laboratories | $815.72 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint |
| Inari Medical, INC. | $640.76 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $606.42 | 2023-2025 | |
| Shockwave Medical, INC | $252.01 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $194.02 | 2023-2025 | Igt Devices Undivided |
| E.R. Squibb & Sons, L.L.C. | $189.97 | 2023-2025 | Camzyos, Eliquis |
| Cardiovascular Systems INC. | $163.35 | 2022 | |
| Medtronic Vascular, INC. | $129.79 | 2019 | |
| Teleflex LLC | $107.03 | 2022-2023 | Guideliner |
| Janssen Pharmaceuticals, INC | $57.20 | 2023 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $51.83 | 2024-2025 | Farxiga, Brilinta |
| Scpharmaceuticals INC. | $37.17 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $20.40 | 2023 | Inpefa |
| Novartis Pharmaceuticals Corporation | $16.65 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mccauley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.